title: Modified neonatal B-cell repertoire as a consequence of rituximab administration to a pregnant woman.
authors: Marco U
authors: MU
authors: Martínez-Martínez
authors: Lourdes
authors: L
authors: Baranda-Cándido
authors: Roberto
authors: R
authors: González-Amaro
authors: Oscar
authors: O
authors: Pérez-Ramírez
authors: Carlos
authors: C
authors: Abud-Mendoza
mesh_terms: D000328:Adult; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D018941:Antigens, CD19 / Q000378:metabolism; D016175:B-Lymphocyte Subsets / Q000187:drug effects* / Q000276:immunology; D051925:CD79 Antigens / Q000378:metabolism; D002452:Cell Count; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D007231:Infant, Newborn; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000188:drug therapy*; D000069283:Rituximab; D055815:Young Adult
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D018941:Antigens, CD19; D051925:CD79 Antigens; D007155:Immunologic Factors; D000069283:Rituximab